These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1553250)

  • 41. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.
    Quartucci C; Rooney JPK; Nowak D; Rakete S
    Int Arch Occup Environ Health; 2023 Jul; 96(5):675-683. PubMed ID: 36877242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ambient monitoring of cyclophosphamide in manufacture and hospitals.
    Pyy L; Sorsa M; Hakala E
    Am Ind Hyg Assoc J; 1988 Jun; 49(6):314-7. PubMed ID: 3400596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.
    Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S
    Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet.
    Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y
    J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new high-performance liquid chromatographic/electrospray ionization tandem mass spectrometric method for the simultaneous determination of cyclophosphamide, methotrexate and 5-fluorouracil as markers of surface contamination for occupational exposure monitoring.
    Sabatini L; Barbieri A; Tosi M; Violante FS
    J Mass Spectrom; 2005 May; 40(5):669-74. PubMed ID: 15739158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-Sectional Evaluation of Surface Contamination with Antineoplastic Drugs in Canadian Health Care Centres.
    Hilliquin D; Tanguay C; Gagné S; Caron NJ; Bussières JF
    Can J Hosp Pharm; 2019; 72(5):377-384. PubMed ID: 31692608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program.
    Chabut C; Tanguay C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2022 Mar; 28(2):343-352. PubMed ID: 33567975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of a decontamination procedure in a pharmacy buffer room contaminated by 5 antineoplastic agents.
    Arpino P; Yeomelakis J; Oommen A
    Am J Health Syst Pharm; 2020 Dec; 77(24):2081-2088. PubMed ID: 33150407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring method for surface contamination caused by selected antineoplastic agents.
    Larson RR; Khazaeli MB; Dillon HK
    Am J Health Syst Pharm; 2002 Feb; 59(3):270-7. PubMed ID: 11862639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sample loss during measurement of airborne antineoplastic agents.
    Hansen TB; Wadden RA
    Am Ind Hyg Assoc J; 1988 Feb; 49(2):58-60. PubMed ID: 3358356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.
    Yuki M; Sekine S; Takase K; Ishida T; Sessink PJ
    J Oncol Pharm Pract; 2013 Sep; 19(3):208-17. PubMed ID: 23060485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations.
    Roberts S; Khammo N; McDonnell G; Sewell GJ
    J Oncol Pharm Pract; 2006 Jun; 12(2):95-104. PubMed ID: 16984748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers.
    Pinet E; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Jan; 30(1):19-29. PubMed ID: 37021440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levels and risks of surface contamination by thirteen antineoplastic drugs in the Czech and Slovak hospitals and pharmacies.
    Doležalová L; Bláhová L; Kuta J; Hojdarová T; Kozáková Š; Bláha L
    Environ Sci Pollut Res Int; 2022 Apr; 29(18):26810-26819. PubMed ID: 34855176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs].
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Frigerio F; Draicchio F; Apostoli P
    G Ital Med Lav Ergon; 1999; 21(2):93-107. PubMed ID: 10771723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy.
    Anastasi M; Rudaz S; Queruau Lamerie T; Odou P; Bonnabry P; Fleury-Souverain S
    Ann Occup Hyg; 2015 Aug; 59(7):895-908. PubMed ID: 25979920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proposals of guidance values for surface contamination by antineoplastic drugs based on long term monitoring in Czech and Slovak hospitals and pharmacies.
    Bláhová L; Bláha L; Doležalová L; Kuta J; Hojdarová T
    Front Public Health; 2023; 11():1235496. PubMed ID: 37780438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
    Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
    Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.